Both medication classes influence metabolic processes, though through different mechanisms, making it important to consider potential interactions and cumulative effects on the body's hormonal and metabolic systems
Animal studies have reported the intragastric application of 10 g/kg BPC-157 as an effective dose, which is estimated to be equivalent to 1.6 g/kg in humans, based on standard dosage conversions
Bottom line GLP-1 patches may sound convenient, but theyre not supported by science, and theyre not a real alternative to prescription treatment
The innovation behind these drugs is the integration of GLP-1 agonistic activity into a GIP-based scaffold, achieving a synergistic, dual activation of both receptors
For example, Shigeta et al
Research demonstrates that IGF-1 stimulates fatty acid uptake and -oxidation in muscle tissue through multiple mechanisms